Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 74 entries
Sorted by: Best Match Show Resources per page
ClinEpiDB: an open-access clinical epidemiology database resource encouraging online exploration of complex studies.

Gates open research

Ruhamyankaka E, Brunk BP, Dorsey G, Harb OS, Helb DA, Judkins J, Kissinger JC, Lindsay B, Roos DS, San EJ, Stoeckert CJ, Zheng J, Tomko SS.
PMID: 32047873
Gates Open Res. 2019 Nov 25;3:1661. doi: 10.12688/gatesopenres.13087.1. eCollection 2019.

The concept of open data has been gaining traction as a mechanism to increase data use, ensure that data are preserved over time, and accelerate discovery. While epidemiology data sets are increasingly deposited in databases and repositories, barriers to...

Cite
Ruhamyankaka E, Brunk BP, Dorsey G, et al. ClinEpiDB: an open-access clinical epidemiology database resource encouraging online exploration of complex studies. Gates Open Res. 2019;3:1661doi: 10.12688/gatesopenres.13087.1.
Ruhamyankaka, E., Brunk, B. P., Dorsey, G., Harb, O. S., Helb, D. A., Judkins, J., Kissinger, J. C., Lindsay, B., Roos, D. S., San, E. J., Stoeckert, C. J., Zheng, J., & Tomko, S. S. (2019). ClinEpiDB: an open-access clinical epidemiology database resource encouraging online exploration of complex studies. Gates open research, 31661. https://doi.org/10.12688/gatesopenres.13087.1
Ruhamyankaka, Emmanuel, et al. "ClinEpiDB: an open-access clinical epidemiology database resource encouraging online exploration of complex studies." Gates open research vol. 3 (2019): 1661. doi: https://doi.org/10.12688/gatesopenres.13087.1
Ruhamyankaka E, Brunk BP, Dorsey G, Harb OS, Helb DA, Judkins J, Kissinger JC, Lindsay B, Roos DS, San EJ, Stoeckert CJ, Zheng J, Tomko SS. ClinEpiDB: an open-access clinical epidemiology database resource encouraging online exploration of complex studies. Gates Open Res. 2019 Nov 25;3:1661. doi: 10.12688/gatesopenres.13087.1. eCollection 2019. PMID: 32047873; PMCID: PMC6993508.
Copy Download .nbib Format: NLM
Synthesis and Characterizations of Macrocyclic Cr(III) and Co(III) 1-Ethynyl Naphthalene and 9-Ethynyl Anthracene Complexes: An Investigation of Structural and Spectroscopic Properties.

Inorganic chemistry

Judkins EC, Zeller M, Ren T.
PMID: 29411976
Inorg Chem. 2018 Feb 19;57(4):2249-2259. doi: 10.1021/acs.inorgchem.7b03128. Epub 2018 Feb 07.

Reported herein are the syntheses and structural and emission spectroscopic characterizations of new Cr

Cite
Judkins EC, Zeller M, Ren T. Synthesis and Characterizations of Macrocyclic Cr(III) and Co(III) 1-Ethynyl Naphthalene and 9-Ethynyl Anthracene Complexes: An Investigation of Structural and Spectroscopic Properties. Inorg Chem. 2018;57(4):2249-2259doi: 10.1021/acs.inorgchem.7b03128.
Judkins, E. C., Zeller, M., & Ren, T. (2018). Synthesis and Characterizations of Macrocyclic Cr(III) and Co(III) 1-Ethynyl Naphthalene and 9-Ethynyl Anthracene Complexes: An Investigation of Structural and Spectroscopic Properties. Inorganic chemistry, 57(4), 2249-2259. https://doi.org/10.1021/acs.inorgchem.7b03128
Judkins, Eileen C, et al. "Synthesis and Characterizations of Macrocyclic Cr(III) and Co(III) 1-Ethynyl Naphthalene and 9-Ethynyl Anthracene Complexes: An Investigation of Structural and Spectroscopic Properties." Inorganic chemistry vol. 57,4 (2018): 2249-2259. doi: https://doi.org/10.1021/acs.inorgchem.7b03128
Judkins EC, Zeller M, Ren T. Synthesis and Characterizations of Macrocyclic Cr(III) and Co(III) 1-Ethynyl Naphthalene and 9-Ethynyl Anthracene Complexes: An Investigation of Structural and Spectroscopic Properties. Inorg Chem. 2018 Feb 19;57(4):2249-2259. doi: 10.1021/acs.inorgchem.7b03128. Epub 2018 Feb 07. PMID: 29411976.
Copy Download .nbib Format: NLM
A case of West Nile virus encephalitis accompanied by diabetic ketoacidosis and rhabdomyolysis.

IDCases

Burden Z, Fasen M, Judkins BL, Isache C.
PMID: 30815360
IDCases. 2019 Feb 13;15:e00505. doi: 10.1016/j.idcr.2019.e00505. eCollection 2019.

INTRODUCTION: We present here a case of West Nile Virus (WNV) encephalitis that initially presented with diabetic ketoacidosis and rhabdomyolysis.CASE PRESENTATION: A 35-year-old male with no past medical history presented to the emergency department complaining of polydipsia, generalized weakness,...

Cite
Burden Z, Fasen M, Judkins BL, et al. A case of West Nile virus encephalitis accompanied by diabetic ketoacidosis and rhabdomyolysis. IDCases. 2019;15:e00505doi: 10.1016/j.idcr.2019.e00505.
Burden, Z., Fasen, M., Judkins, B. L., & Isache, C. (2019). A case of West Nile virus encephalitis accompanied by diabetic ketoacidosis and rhabdomyolysis. IDCases, 15e00505. https://doi.org/10.1016/j.idcr.2019.e00505
Burden, Zachary, et al. "A case of West Nile virus encephalitis accompanied by diabetic ketoacidosis and rhabdomyolysis." IDCases vol. 15 (2019): e00505. doi: https://doi.org/10.1016/j.idcr.2019.e00505
Burden Z, Fasen M, Judkins BL, Isache C. A case of West Nile virus encephalitis accompanied by diabetic ketoacidosis and rhabdomyolysis. IDCases. 2019 Feb 13;15:e00505. doi: 10.1016/j.idcr.2019.e00505. eCollection 2019. PMID: 30815360; PMCID: PMC6378900.
Copy Download .nbib Format: NLM
Developing hardiness in nurse managers.

Nursing management (Harrow, London, England : 1994)

Judkins S, Furlow L, Kendricks T.
PMID: 27732172
Nurs Manag (Harrow). 2007 Nov 01;14(7):19-23. doi: 10.7748/nm.14.7.19.s14.

ALL AROUND the world, countries currently face the most severe nursing shortage in history ( Hatcher 2006 ). This shortage stems partly from the effect on employees, and ultimately therefore on organisations ( Judkins and Furlow 2004 ), of...

Cite
Judkins S, Furlow L, Kendricks T. Developing hardiness in nurse managers. Nurs Manag (Harrow). 2007;14(7):19-23doi: 10.7748/nm.14.7.19.s14.
Judkins, S., Furlow, L., & Kendricks, T. (2007). Developing hardiness in nurse managers. Nursing management (Harrow, London, England : 1994), 14(7), 19-23. https://doi.org/10.7748/nm.14.7.19.s14
Judkins, Sharon, et al. "Developing hardiness in nurse managers." Nursing management (Harrow, London, England : 1994) vol. 14,7 (2007): 19-23. doi: https://doi.org/10.7748/nm.14.7.19.s14
Judkins S, Furlow L, Kendricks T. Developing hardiness in nurse managers. Nurs Manag (Harrow). 2007 Nov 01;14(7):19-23. doi: 10.7748/nm.14.7.19.s14. PMID: 27732172.
Copy Download .nbib Format: NLM
femoral neck fracture during physical therapy following surface replacement arthroplasty: a preventable complication? A case report.

Patient safety in surgery

Judkins TR, Dayton MR.
PMID: 20181092
Patient Saf Surg. 2010 Feb 04;4(1):3. doi: 10.1186/1754-9493-4-3.

This case report describes two cases of peri-prosthetic fracture during physical therapy in patients who underwent a hip resurfacing, or surface replacement arthroplasty. The fractures occurred with forceful passive combined flexion and external rotation. Functional results were ultimately obtained...

Cite
Judkins TR, Dayton MR. femoral neck fracture during physical therapy following surface replacement arthroplasty: a preventable complication? A case report. Patient Saf Surg. 2010;4(1):3doi: 10.1186/1754-9493-4-3.
Judkins, T. R., & Dayton, M. R. (2010). femoral neck fracture during physical therapy following surface replacement arthroplasty: a preventable complication? A case report. Patient safety in surgery, 4(1), 3. https://doi.org/10.1186/1754-9493-4-3
Judkins, Timothy R, and Dayton, Michael R. "femoral neck fracture during physical therapy following surface replacement arthroplasty: a preventable complication? A case report." Patient safety in surgery vol. 4,1 (2010): 3. doi: https://doi.org/10.1186/1754-9493-4-3
Judkins TR, Dayton MR. femoral neck fracture during physical therapy following surface replacement arthroplasty: a preventable complication? A case report. Patient Saf Surg. 2010 Feb 04;4(1):3. doi: 10.1186/1754-9493-4-3. PMID: 20181092; PMCID: PMC2829516.
Copy Download .nbib Format: NLM
Long-period fiber-grating-based gain equalizers.

Optics letters

Vengsarkar AM, Pedrazzani JR, Judkins JB, Lemaire PJ, Bergano NS, Davidson CR.
PMID: 19865397
Opt Lett. 1996 Mar 01;21(5):336-8. doi: 10.1364/ol.21.000336.

Long-period fiber gratings are used to f latten the gain spectrum of erbium-doped fiber amplifiers. A broadband amplifier with

Cite
Vengsarkar AM, Pedrazzani JR, Judkins JB, et al. Long-period fiber-grating-based gain equalizers. Opt Lett. 1996;21(5):336-8doi: 10.1364/ol.21.000336.
Vengsarkar, A. M., Pedrazzani, J. R., Judkins, J. B., Lemaire, P. J., Bergano, N. S., & Davidson, C. R. (1996). Long-period fiber-grating-based gain equalizers. Optics letters, 21(5), 336-8. https://doi.org/10.1364/ol.21.000336
Vengsarkar, A M, et al. "Long-period fiber-grating-based gain equalizers." Optics letters vol. 21,5 (1996): 336-8. doi: https://doi.org/10.1364/ol.21.000336
Vengsarkar AM, Pedrazzani JR, Judkins JB, Lemaire PJ, Bergano NS, Davidson CR. Long-period fiber-grating-based gain equalizers. Opt Lett. 1996 Mar 01;21(5):336-8. doi: 10.1364/ol.21.000336. PMID: 19865397.
Copy Download .nbib Format: NLM
Using the NIATx Model to Implement User-Centered Design of Technology for Older Adults.

JMIR human factors

Gustafson DH, Maus A, Judkins J, Dinauer S, Isham A, Johnson R, Landucci G, Atwood AK.
PMID: 27025985
JMIR Hum Factors. 2016 Jan 14;3(1):e2. doi: 10.2196/humanfactors.4853.

What models can effectively guide the creation of eHealth and mHealth technologies? This paper describes the use of the NIATx model as a framework for the user-centered design of a new technology for older adults. The NIATx model is...

Cite
Gustafson DH, Maus A, Judkins J, et al. Using the NIATx Model to Implement User-Centered Design of Technology for Older Adults. JMIR Hum Factors. 2016;3(1):e2doi: 10.2196/humanfactors.4853.
Gustafson, D. H., Maus, A., Judkins, J., Dinauer, S., Isham, A., Johnson, R., Landucci, G., & Atwood, A. K. (2016). Using the NIATx Model to Implement User-Centered Design of Technology for Older Adults. JMIR human factors, 3(1), e2. https://doi.org/10.2196/humanfactors.4853
Gustafson, David H, et al. "Using the NIATx Model to Implement User-Centered Design of Technology for Older Adults." JMIR human factors vol. 3,1 (2016): e2. doi: https://doi.org/10.2196/humanfactors.4853
Gustafson DH, Maus A, Judkins J, Dinauer S, Isham A, Johnson R, Landucci G, Atwood AK. Using the NIATx Model to Implement User-Centered Design of Technology for Older Adults. JMIR Hum Factors. 2016 Jan 14;3(1):e2. doi: 10.2196/humanfactors.4853. PMID: 27025985; PMCID: PMC4797701.
Copy Download .nbib Format: NLM
Association of Intrapartum Drugs with Spontaneous Intestinal Perforation: A Single-Center Retrospective Review.

American journal of perinatology

Mantle A, Yang MJ, Judkins A, Chanthavong I, Yoder BA, Chan B.
PMID: 34666387
Am J Perinatol. 2021 Oct 19; doi: 10.1055/a-1673-0183. Epub 2021 Oct 19.

OBJECTIVE:  Spontaneous intestinal perforation (SIP) occurs commonly in extremely low gestational age newborns (ELGANs;

Cite
Mantle A, Yang MJ, Judkins A, et al. Association of Intrapartum Drugs with Spontaneous Intestinal Perforation: A Single-Center Retrospective Review. Am J Perinatol. 2021;doi: 10.1055/a-1673-0183.
Mantle, A., Yang, M. J., Judkins, A., Chanthavong, I., Yoder, B. A., & Chan, B. (2021). Association of Intrapartum Drugs with Spontaneous Intestinal Perforation: A Single-Center Retrospective Review. American journal of perinatology, . https://doi.org/10.1055/a-1673-0183
Mantle, Ashley, et al. "Association of Intrapartum Drugs with Spontaneous Intestinal Perforation: A Single-Center Retrospective Review." American journal of perinatology vol. (2021). doi: https://doi.org/10.1055/a-1673-0183
Mantle A, Yang MJ, Judkins A, Chanthavong I, Yoder BA, Chan B. Association of Intrapartum Drugs with Spontaneous Intestinal Perforation: A Single-Center Retrospective Review. Am J Perinatol. 2021 Oct 19; doi: 10.1055/a-1673-0183. Epub 2021 Oct 19. PMID: 34666387.
Copy Download .nbib Format: NLM
Persistent SARS-CoV-2 infection and increasing viral variants in children and young adults with impaired humoral immunity.

medRxiv : the preprint server for health sciences

Truong TT, Ryutov A, Pandey U, Yee R, Goldberg L, Bhojwani D, Aguayo-Hiraldo P, Pinsky BA, Pekosz A, Shen L, Boyd SD, Wirz OF, Röltgen K, Bootwalla M, Maglinte DT, Ostrow D, Ruble D, Han JH, Biegel JA, Li M, Huang C, Sahoo MK, Pannaraj PS, O'Gorman M, Judkins AR, Gai X, Bard JD.
PMID: 33688673
medRxiv. 2021 Mar 02; doi: 10.1101/2021.02.27.21252099.

BACKGROUND: There is increasing concern that persistent infection of SARS-CoV-2 within immunocompromised hosts could serve as a reservoir for mutation accumulation and subsequent emergence of novel strains with the potential to evade immune responses.METHODS: We describe three patients with...

Cite
Truong TT, Ryutov A, Pandey U, et al. Persistent SARS-CoV-2 infection and increasing viral variants in children and young adults with impaired humoral immunity. medRxiv. 2021;doi: 10.1101/2021.02.27.21252099.
Truong, T. T., Ryutov, A., Pandey, U., Yee, R., Goldberg, L., Bhojwani, D., Aguayo-Hiraldo, P., Pinsky, B. A., Pekosz, A., Shen, L., Boyd, S. D., Wirz, O. F., Röltgen, K., Bootwalla, M., Maglinte, D. T., Ostrow, D., Ruble, D., Han, J. H., Biegel, J. A., Li, M., Huang, C., Sahoo, M. K., Pannaraj, P. S., O'Gorman, M., Judkins, A. R., Gai, X., & Bard, J. D. (2021). Persistent SARS-CoV-2 infection and increasing viral variants in children and young adults with impaired humoral immunity. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2021.02.27.21252099
Truong, Thao T, et al. "Persistent SARS-CoV-2 infection and increasing viral variants in children and young adults with impaired humoral immunity." medRxiv : the preprint server for health sciences vol. (2021). doi: https://doi.org/10.1101/2021.02.27.21252099
Truong TT, Ryutov A, Pandey U, Yee R, Goldberg L, Bhojwani D, Aguayo-Hiraldo P, Pinsky BA, Pekosz A, Shen L, Boyd SD, Wirz OF, Röltgen K, Bootwalla M, Maglinte DT, Ostrow D, Ruble D, Han JH, Biegel JA, Li M, Huang C, Sahoo MK, Pannaraj PS, O'Gorman M, Judkins AR, Gai X, Bard JD. Persistent SARS-CoV-2 infection and increasing viral variants in children and young adults with impaired humoral immunity. medRxiv. 2021 Mar 02; doi: 10.1101/2021.02.27.21252099. PMID: 33688673; PMCID: PMC7941650.
Copy Download .nbib Format: NLM
A feasibility study of combined epigenetic and vaccine therapy in advanced colorectal cancer with pharmacodynamic endpoint.

Clinical epigenetics

Bever KM, Thomas DL, Zhang J, Diaz Rivera EA, Rosner GL, Zhu Q, Nauroth JM, Christmas B, Thompson ED, Anders RA, Judkins C, Liu M, Jaffee EM, Ahuja N, Zheng L, Azad NS.
PMID: 33531075
Clin Epigenetics. 2021 Feb 02;13(1):25. doi: 10.1186/s13148-021-01014-8.

Epigenetic therapies may modulate the tumor microenvironment. We evaluated the safety and optimal sequence of combination DNA methyltransferase inhibitor guadecitabine with a granulocyte macrophage-colony-stimulating-factor (GM-CSF) secreting colon cancer (CRC) vaccine (GVAX) using a primary endpoint of change in CD45RO...

Cite
Bever KM, Thomas DL, Zhang J, et al. A feasibility study of combined epigenetic and vaccine therapy in advanced colorectal cancer with pharmacodynamic endpoint. Clin Epigenetics. 2021;13(1):25doi: 10.1186/s13148-021-01014-8.
Bever, K. M., Thomas, D. L., Zhang, J., Diaz Rivera, E. A., Rosner, G. L., Zhu, Q., Nauroth, J. M., Christmas, B., Thompson, E. D., Anders, R. A., Judkins, C., Liu, M., Jaffee, E. M., Ahuja, N., Zheng, L., & Azad, N. S. (2021). A feasibility study of combined epigenetic and vaccine therapy in advanced colorectal cancer with pharmacodynamic endpoint. Clinical epigenetics, 13(1), 25. https://doi.org/10.1186/s13148-021-01014-8
Bever, Katherine M, et al. "A feasibility study of combined epigenetic and vaccine therapy in advanced colorectal cancer with pharmacodynamic endpoint." Clinical epigenetics vol. 13,1 (2021): 25. doi: https://doi.org/10.1186/s13148-021-01014-8
Bever KM, Thomas DL, Zhang J, Diaz Rivera EA, Rosner GL, Zhu Q, Nauroth JM, Christmas B, Thompson ED, Anders RA, Judkins C, Liu M, Jaffee EM, Ahuja N, Zheng L, Azad NS. A feasibility study of combined epigenetic and vaccine therapy in advanced colorectal cancer with pharmacodynamic endpoint. Clin Epigenetics. 2021 Feb 02;13(1):25. doi: 10.1186/s13148-021-01014-8. PMID: 33531075; PMCID: PMC7856736.
Copy Download .nbib Format: NLM
Motivations to Vaccinate Among Hesitant Adopters of the COVID-19 Vaccine.

Journal of community health

Moore R, Purvis RS, Hallgren E, Willis DE, Hall S, Reece S, CarlLee S, Judkins H, McElfish PA.
PMID: 34687388
J Community Health. 2021 Oct 23; doi: 10.1007/s10900-021-01037-5. Epub 2021 Oct 23.

Vaccination is a critical means for mitigating the worst effects of the COVID-19 pandemic in the United States (US). However, the initial high demand for COVID-19 vaccines has not persisted, and the rate of vaccination slowed significantly in the...

Cite
Moore R, Purvis RS, Hallgren E, et al. Motivations to Vaccinate Among Hesitant Adopters of the COVID-19 Vaccine. J Community Health. 2021;doi: 10.1007/s10900-021-01037-5.
Moore, R., Purvis, R. S., Hallgren, E., Willis, D. E., Hall, S., Reece, S., CarlLee, S., Judkins, H., & McElfish, P. A. (2021). Motivations to Vaccinate Among Hesitant Adopters of the COVID-19 Vaccine. Journal of community health, . https://doi.org/10.1007/s10900-021-01037-5
Moore, Ramey, et al. "Motivations to Vaccinate Among Hesitant Adopters of the COVID-19 Vaccine." Journal of community health vol. (2021). doi: https://doi.org/10.1007/s10900-021-01037-5
Moore R, Purvis RS, Hallgren E, Willis DE, Hall S, Reece S, CarlLee S, Judkins H, McElfish PA. Motivations to Vaccinate Among Hesitant Adopters of the COVID-19 Vaccine. J Community Health. 2021 Oct 23; doi: 10.1007/s10900-021-01037-5. Epub 2021 Oct 23. PMID: 34687388; PMCID: PMC8536476.
Copy Download .nbib Format: NLM
Whose Data, Whose Risk? Omics Privacy Concerns Should be Defined by Individuals, not Researchers.

The American journal of bioethics : AJOB

Derrington SF, Deardorff MA, Judkins AR, Gai X.
PMID: 34806958
Am J Bioeth. 2021 Dec;21(12):67-70. doi: 10.1080/15265161.2021.1991040.

No abstract available.

Cite
Derrington SF, Deardorff MA, Judkins AR, et al. Whose Data, Whose Risk? Omics Privacy Concerns Should be Defined by Individuals, not Researchers. Am J Bioeth. 2021;21(12):67-70doi: 10.1080/15265161.2021.1991040.
Derrington, S. F., Deardorff, M. A., Judkins, A. R., & Gai, X. (2021). Whose Data, Whose Risk? Omics Privacy Concerns Should be Defined by Individuals, not Researchers. The American journal of bioethics : AJOB, 21(12), 67-70. https://doi.org/10.1080/15265161.2021.1991040
Derrington, Sabrina F, et al. "Whose Data, Whose Risk? Omics Privacy Concerns Should be Defined by Individuals, not Researchers." The American journal of bioethics : AJOB vol. 21,12 (2021): 67-70. doi: https://doi.org/10.1080/15265161.2021.1991040
Derrington SF, Deardorff MA, Judkins AR, Gai X. Whose Data, Whose Risk? Omics Privacy Concerns Should be Defined by Individuals, not Researchers. Am J Bioeth. 2021 Dec;21(12):67-70. doi: 10.1080/15265161.2021.1991040. PMID: 34806958.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 74 entries